logo
Select company
Select metric
-12.47%Free Cash Flow Yield
VS
Market
23
Sector
55
Industry
74
History
57
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Free Cash Flow Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - FCF Yield Historical data
DateFree Cash FlowFree Cash Flow YieldMarket Capitalization
6/30/2025$ -32.94M-12.47%$ 264.1M
3/31/2025$ -33.19M-9%$ 368.88M
12/31/2024$ -32.83M-8.71%$ 376.83M
9/30/2024$ 00%$ 636.1M
6/30/2024$ -20.03M-3.46%$ 578.49M
3/31/2024$ 00%$ 444.66M
12/31/2023$ -21.13M-5.02%$ 420.82M
6/30/2023$ -42.02M-22.84%$ 183.96M
12/31/2022$ -48.54M-51.23%$ 94.74M
6/30/2022$ -43.12M-41.27%$ 104.46M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) FCF Yield stands at -15.52%.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average FCF Yield has been -16.23%.
  • The median FCF Yield for MEREO BIOPHARMA GROUP PLC during this period was -9%
  • MEREO BIOPHARMA GROUP PLC reached its highest FCF Yield over the past 5 years at -3.46%.
  • The lowest FCF Yield recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe -51.23%

MEREO BIOPHARMA GROUP PLC's FCF Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Yield Benchmarks
CompanyFCF Yield
CRDF : CARDIFF ONCOLOGY INC -19.01%ABEO : ABEONA THERAPEUTICS INC -19.23%HUMA : HUMACYTE INC -38.46%AVTX : AVALO THERAPEUTICS INC -43.18%COYA : COYA THERAPEUTICS INC -16.07%ABVC : ABVC BIOPHARMA INC -2.51%FDMT : 4D MOLECULAR THERAPEUTICS INC -65.75%VTGN : VISTAGEN THERAPEUTICS INC -60.04%ERNA : ERNEXA THERAPEUTICS INC -115.54%ANNX : ANNEXON INC -59.75%

Definition of Free Cash Flow Yield

[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
FCF / Market Cap
(=) FCF Yield
FCF Yield for MEREO BIOPHARMA GROUP PLC is calculated as follows: FCF [ $ -35.45M ] / Market Cap [ $ 228.45M ]
(=) FCF Yield [ -15.52% ]

MREO - Free Cash Flow Yield, Last 5 years

-51.23%

Minimum

Dec 31, 2022

-3.46%

Maximum

Jun 30, 2024

-16.23%

Average

-9%

Median

FCF Yield Benchmark Analysis

The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.59% with a standard deviation of 11.38%.
The following table provides additional summary stats:
FCF Yield in the Market:
filtered constituents3.58K
min-33.87%
max37.55%
average1.59%
median3.22%
std11.38%